Halozyme Therapeutics logo

Halozyme Therapeutics

10 followers

Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies.

Industries

Employees

51-200

Links


Org chart

Helen Torley
President & CEO
Collapse
Benjamin J. Hickey
Senior Vice President, Chief Commercial Officer
Dimitrios Chondros
Senior Vice President, Chief Medical Officer
Ed Gemo
Vice President and Chief Information Officer
Michael E. Paolucci
Vice President and Chief Human Resources Officer
Gilbert Keller
Senior Research Fellow And Executive Director
Aubrey Haddach
Executive Director, Intellectual Property
Charles Theuer
Chief Medical Officer
Chris Wahl
Chief Scientific Officer
Darren Snellgrove
Chief Financial Officer
Mark Snyder
Chief Legal Officer
Chase Coffman
President of Hypercon™
Rhys de Callier
Chief Strategy Officer (CSO)
Paul Spence
Chief Commercial Officer (CCO)
Lisa Correia
Vice President, Operations Strategy And Supply Chain
Chris Makely
Vice President, Drug Substance And Device Manufacturing, Development And Supply Chain
Anna-Maria Hays Putnam
Vice President and Head, Surf Bio Business Unit
Kristin Schwartzbauer
Vp, Quality | Head Of Quality
Angela Hui
Vice President Operations
Paul Brown
Vice President, Drug Product Innovation

Board & advisors

Jim Lang
Director
Jeffrey W. Henderson
Chair of the Board